These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 9143222)

  • 21. A new rat model of thrombotic focal cerebral ischemia.
    Zhang Z; Zhang RL; Jiang Q; Raman SB; Cantwell L; Chopp M
    J Cereb Blood Flow Metab; 1997 Feb; 17(2):123-35. PubMed ID: 9040491
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recanalization between 1 and 24 hours after t-PA therapy is a strong predictor of cerebral hemorrhage in acute ischemic stroke patients.
    Kimura K; Iguchi Y; Shibazaki K; Kobayashi K; Uemura J; Aoki J; Yamashita S; Terasawa Y; Matsumoto N
    J Neurol Sci; 2008 Jul; 270(1-2):48-52. PubMed ID: 18304581
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Magnetic resonance imaging characterization of hemorrhagic transformation of embolic stroke in the rat.
    Jiang Q; Zhang RL; Zhang ZG; Knight RA; Ewing JR; Ding G; Lu M; Arniego P; Zhang L; Hu J; Li Q; Chopp M
    J Cereb Blood Flow Metab; 2002 May; 22(5):559-68. PubMed ID: 11973428
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hirulog-1 reduces expression of platelet-derived growth factor in neointima of rat carotid artery induced by balloon catheter injury.
    Xue M; Fenton JW; Shen GX
    J Vasc Res; 2000; 37(2):82-92. PubMed ID: 10754393
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FK-506 extended the therapeutic time window for thrombolysis without increasing the risk of hemorrhagic transformation in an embolic rat stroke model.
    Okubo S; Igarashi H; Kanamatsu T; Hasegawa D; Orima H; Katayama Y
    Brain Res; 2007 Apr; 1143():221-7. PubMed ID: 17316578
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of pretreatment MRI parameters on clinical outcome, recanalization and infarct size in 49 stroke patients treated by intravenous tissue plasminogen activator.
    Derex L; Nighoghossian N; Hermier M; Adeleine P; Berthezène Y; Philippeau F; Honnorat J; Froment JC; Trouillas P
    J Neurol Sci; 2004 Oct; 225(1-2):3-9. PubMed ID: 15465079
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antithrombotic effects of hirulog in a rat carotid endarterectomy model.
    Jackson MR; Reid TJ; Tang DB; O'Donnell SD; Gomez ER; Alving BM
    J Surg Res; 1996 Jan; 60(1):15-22. PubMed ID: 8592407
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Significance of magnetic resonance angiography-diffusion weighted imaging mismatch in hyperacute cerebral infarction.
    Deguchi I; Takeda H; Furuya D; Dembo T; Nagoya H; Kato Y; Ito Y; Fukuoka T; Maruyama H; Tanahashi N
    J Stroke Cerebrovasc Dis; 2012 Feb; 21(2):108-13. PubMed ID: 20851627
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combination Therapy Stroke Trial: recombinant tissue-type plasminogen activator with/without lubeluzole.
    Grotta J;
    Cerebrovasc Dis; 2001; 12(3):258-63. PubMed ID: 11641593
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic impact of baseline cerebral blood flow in patients with acute ischemic stroke prior to intravenous recombinant tissue plasminogen activator therapy.
    Ito M; Yoshimoto T; Kawabori M; Fujimoto S; Yamauchi T; Yamaguchi H; Tokuda K; Kaneko S
    Clin Neurol Neurosurg; 2013 Aug; 115(8):1464-9. PubMed ID: 23434471
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathophysiology and mechanisms of acute ischemic stroke. The NINDS rt-PA Stroke Study Group.
    Bratina P; Rapp K; Barch C; Kongable G; Donnarumma R; Spilker J; Daley S; Braimah J; Sailor S
    J Neurosci Nurs; 1997 Dec; 29(6):356-60. PubMed ID: 9479656
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of platelet deposition by combined hirulog and aspirin in a rat carotid endarterectomy model.
    Hamelink JK; Tang DB; Barr CF; Jackson MR; Reid TJ; Gomez ER; Alving BM
    J Vasc Surg; 1995 Mar; 21(3):492-8. PubMed ID: 7877232
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of intravenous tissue-type plasminogen activator in a rat model of embolic cerebral ischemia.
    Penar PL; Greer CA
    Yale J Biol Med; 1987; 60(3):233-43. PubMed ID: 3111108
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduced dose bolus alteplase vs conventional alteplase infusion for pulmonary embolism thrombolysis. An international multicenter randomized trial. The Bolus Alteplase Pulmonary Embolism Group.
    Goldhaber SZ; Agnelli G; Levine MN
    Chest; 1994 Sep; 106(3):718-24. PubMed ID: 8082347
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sensitivity of diffusion- and perfusion-weighted imaging for diagnosing acute ischemic stroke is 97.5%.
    Simonsen CZ; Madsen MH; Schmitz ML; Mikkelsen IK; Fisher M; Andersen G
    Stroke; 2015 Jan; 46(1):98-101. PubMed ID: 25388415
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optimized thrombolysis of cerebral clots with tissue-type plasminogen activator in a rabbit model of embolic stroke.
    Thomas GR; Thibodeaux H; Bennett WF; Refino CJ; Badillo JM; Errett CJ; Zivin JA
    J Pharmacol Exp Ther; 1993 Jan; 264(1):67-73. PubMed ID: 8423552
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk for symptomatic intracerebral hemorrhage after thrombolysis assessed by diffusion-weighted magnetic resonance imaging.
    Singer OC; Humpich MC; Fiehler J; Albers GW; Lansberg MG; Kastrup A; Rovira A; Liebeskind DS; Gass A; Rosso C; Derex L; Kim JS; Neumann-Haefelin T;
    Ann Neurol; 2008 Jan; 63(1):52-60. PubMed ID: 17880020
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Do acute diffusion- and perfusion-weighted MRI lesions identify final infarct volume in ischemic stroke?
    Rivers CS; Wardlaw JM; Armitage PA; Bastin ME; Carpenter TK; Cvoro V; Hand PJ; Dennis MS
    Stroke; 2006 Jan; 37(1):98-104. PubMed ID: 16322499
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reperfusion after thrombolytic therapy of embolic stroke in the rat: magnetic resonance and biochemical imaging.
    Busch E; Krüger K; Allegrini PR; Kerskens CM; Gyngell ML; Hoehn-Berlage M; Hossmann KA
    J Cereb Blood Flow Metab; 1998 Apr; 18(4):407-18. PubMed ID: 9538906
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Magnetic resonance imaging indexes of therapeutic efficacy of recombinant tissue plasminogen activator treatment of rat at 1 and 4 hours after embolic stroke.
    Jiang Q; Zhang RL; Zhang ZG; Ewing JR; Jiang P; Divine GW; Knight RA; Chopp M
    J Cereb Blood Flow Metab; 2000 Jan; 20(1):21-7. PubMed ID: 10616789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.